| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $152.3M | -12.9% |
| Cost of Revenue | $102.5M | -10.6% |
| R&D Expense | $26.2M | -10.7% |
| SG&A Expense | $43.2M | -20.4% |
| Operating Income | -$64.0M | -53.2% |
| Pre-tax Income | -$60.5M | -81.3% |
| Income Tax | $41K | -84.6% |
| Net Income | -$60.6M | -80.0% |
| EPS (Basic) | -$0.32 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $104.5M | -26.6% |
| Accounts Receivable | $47.4M | -20.1% |
| Inventory | $26.7M | -24.4% |
| Current Assets | $187.9M | -27.1% |
| Total Assets | $320.9M | -23.6% |
| Current Liabilities | $60.0M | -15.5% |
| Total Liabilities | $88.8M | -32.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$21.6M | +34.4% |
| Capital Expenditures | $3.6M | +101.1% |
| Investing Cash Flow | -$8.6M | -13.5% |
| Financing Cash Flow | -$7.4M | +77.4% |
| Free Cash Flow | -$25.1M | +27.5% |
| -88.2% |
| EPS (Diluted) | -$0.32 | -88.2% |
| Stockholders' Equity |
| $232.1M |
| -19.8% |